drugset / Trial / NCT02040623
Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
* To assess the efficacy of R348 Ophthalmic Solutions administered for 12 weeks to subjects evaluated by objective and subjective measures. * To investigate the safety and tolerability of R348 Ophthalmic Solutions administered for 12 weeks to subjects.
Timeline
- Start
- 2014-03
- Primary completion
- 2016-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | R348 | Small molecule | 0.2 % | Other |
| Comparator | R348 | Small molecule | 0.5 % | Other |